Arimidex in McCune Albright Syndrome

Mise à jour : Il y a 4 ans
Référence : NCT00055302

Femme Homme

Extrait

The primary objective of this study is to evaluate the safety and efficacy of anastrozole 1 mg given once daily in subjects with McCune-Albright Syndrome.


Critère d'inclusion

  • McCune-Albright Syndrome


Liens